Additional files 2: of RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis

Table S2 Tumor responses (RECIST v1.0) of Asian and non-Asian patients in the overall population and in the first-line therapy cohorts. (DOCX 13 kb)